Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR

21.38  +0.74 (+3.59%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICAD. ICAD was compared to 43 industry peers in the Diversified REITs industry. While ICAD seems to be doing ok healthwise, there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ICAD.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ICAD was profitable.
In the past year ICAD had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of ICAD (-8.83%) is worse than 87.50% of its industry peers.
Looking at the Return On Equity, with a value of -21.52%, ICAD is doing worse than 92.50% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.61%, ICAD is doing worse than 85.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ICAD is in line with the industry average of 3.77%.
Industry RankSector Rank
ROA -8.83%
ROE -21.52%
ROIC 1.61%
ROA(3y)-2.74%
ROA(5y)-1.07%
ROE(3y)-6.1%
ROE(5y)-1.52%
ROIC(3y)2.98%
ROIC(5y)2.88%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

With a Operating Margin value of 10.13%, ICAD is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ICAD has grown nicely.
The Profit Margin and Gross Margin are not available for ICAD so they could not be analyzed.
Industry RankSector Rank
OM 10.13%
PM (TTM) N/A
GM N/A
OM growth 3Y-26.2%
OM growth 5Y5.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

ICAD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
There is no outstanding debt for ICAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.83, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
ICAD's Altman-Z score of 0.83 is in line compared to the rest of the industry. ICAD outperforms 45.00% of its industry peers.
The Debt to FCF ratio of ICAD is 47.43, which is on the high side as it means it would take ICAD, 47.43 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 47.43, ICAD is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
ICAD has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
ICAD has a Debt to Equity ratio of 1.07. This is amonst the worse of the industry: ICAD underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 47.43
Altman-Z 0.83
ROIC/WACC0.58
WACC2.78%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.04 indicates that ICAD has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.04, ICAD belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
A Quick Ratio of 1.69 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD has a Quick ratio of 1.69. This is amongst the best in the industry. ICAD outperforms 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.69
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 148.29% over the past year.
Measured over the past years, ICAD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.35% on average per year.
ICAD shows a small growth in Revenue. In the last year, the Revenue has grown by 1.13%.
Measured over the past years, ICAD shows a decrease in Revenue. The Revenue has been decreasing by -1.33% on average per year.
EPS 1Y (TTM)148.29%
EPS 3Y-15.89%
EPS 5Y-11.35%
EPS Q2Q%0.16%
Revenue 1Y (TTM)1.13%
Revenue growth 3Y4.78%
Revenue growth 5Y-1.33%
Sales Q2Q%285.92%

3.2 Future

The Earnings Per Share is expected to decrease by -0.39% on average over the next years.
The Revenue is expected to grow by 46.32% on average over the next years. This is a very strong growth
EPS Next Y35.15%
EPS Next 2Y9.99%
EPS Next 3Y3.09%
EPS Next 5Y-0.39%
Revenue Next Year-17.73%
Revenue Next 2Y-10.15%
Revenue Next 3Y-7.46%
Revenue Next 5Y46.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.55 indicates a rather cheap valuation of ICAD.
Based on the Price/Earnings ratio, ICAD is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
ICAD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 6.27, the valuation of ICAD can be described as very cheap.
Based on the Price/Forward Earnings ratio, ICAD is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ICAD to the average of the S&P500 Index (22.68), we can say ICAD is valued rather cheaply.
Industry RankSector Rank
PE 7.55
Fwd PE 6.27
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

90.00% of the companies in the same industry are more expensive than ICAD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICAD indicates a slightly more expensive valuation: ICAD is more expensive than 65.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.23
EV/EBITDA 10.86
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y9.99%
EPS Next 3Y3.09%

6

5. Dividend

5.1 Amount

ICAD has a Yearly Dividend Yield of 20.88%, which is a nice return.
ICAD's Dividend Yield is rather good when compared to the industry average which is at 8.20. ICAD pays more dividend than 95.00% of the companies in the same industry.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 20.88%

5.2 History

The dividend of ICAD has a limited annual growth rate of 0.17%.
Dividend Growth(5Y)0.17%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-36.7%
EPS Next 2Y9.99%
EPS Next 3Y3.09%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (2/21/2025, 7:00:00 PM)

21.38

+0.74 (+3.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)07-23 2025-07-23
Inst Owners72.42%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.63B
Analysts73.33
Price Target28.2 (31.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 20.88%
Yearly Dividend4.33
Dividend Growth(5Y)0.17%
DP-36.7%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.63%
PT rev (3m)-6.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.51%
EPS NY rev (3m)3.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 7.55
Fwd PE 6.27
P/S 0.98
P/FCF 16.23
P/OCF 4.85
P/B 0.37
P/tB 0.37
EV/EBITDA 10.86
EPS(TTM)2.83
EY13.24%
EPS(NY)3.41
Fwd EY15.96%
FCF(TTM)1.32
FCFY6.16%
OCF(TTM)4.41
OCFY20.62%
SpS21.77
BVpS58.25
TBVpS57.84
PEG (NY)0.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.83%
ROE -21.52%
ROCE 1.9%
ROIC 1.61%
ROICexc 1.92%
ROICexgc 1.93%
OM 10.13%
PM (TTM) N/A
GM N/A
FCFM 6.05%
ROA(3y)-2.74%
ROA(5y)-1.07%
ROE(3y)-6.1%
ROE(5y)-1.52%
ROIC(3y)2.98%
ROIC(5y)2.88%
ROICexc(3y)3.3%
ROICexc(5y)3.17%
ROICexgc(3y)3.32%
ROICexgc(5y)3.19%
ROCE(3y)3.53%
ROCE(5y)3.35%
ROICexcg growth 3Y-9.07%
ROICexcg growth 5Y5.26%
ROICexc growth 3Y-9.03%
ROICexc growth 5Y5.32%
OM growth 3Y-26.2%
OM growth 5Y5.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 47.43
Debt/EBITDA 12.9
Cap/Depr 118.57%
Cap/Sales 14.2%
Interest Coverage 2
Cash Conversion 91.63%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.69
Altman-Z 0.83
F-Score5
WACC2.78%
ROIC/WACC0.58
Cap/Depr(3y)1452.57%
Cap/Depr(5y)1267.55%
Cap/Sales(3y)36.78%
Cap/Sales(5y)39.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)148.29%
EPS 3Y-15.89%
EPS 5Y-11.35%
EPS Q2Q%0.16%
EPS Next Y35.15%
EPS Next 2Y9.99%
EPS Next 3Y3.09%
EPS Next 5Y-0.39%
Revenue 1Y (TTM)1.13%
Revenue growth 3Y4.78%
Revenue growth 5Y-1.33%
Sales Q2Q%285.92%
Revenue Next Year-17.73%
Revenue Next 2Y-10.15%
Revenue Next 3Y-7.46%
Revenue Next 5Y46.32%
EBIT growth 1Y-62.98%
EBIT growth 3Y-22.67%
EBIT growth 5Y4.12%
EBIT Next Year70.78%
EBIT Next 3Y18.87%
EBIT Next 5Y12.63%
FCF growth 1Y115.44%
FCF growth 3Y-68.88%
FCF growth 5YN/A
OCF growth 1Y14.44%
OCF growth 3Y-22.03%
OCF growth 5Y-2.86%